AMG National Trust Bank Has $993,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

AMG National Trust Bank lessened its position in Colgate-Palmolive (NYSE:CL - Free Report) by 68.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,563 shares of the company's stock after selling 20,633 shares during the quarter. AMG National Trust Bank's holdings in Colgate-Palmolive were worth $993,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Main Street Research LLC boosted its position in shares of Colgate-Palmolive by 1.5% during the 2nd quarter. Main Street Research LLC now owns 6,939 shares of the company's stock valued at $673,000 after acquiring an additional 100 shares in the last quarter. Advisor OS LLC boosted its position in shares of Colgate-Palmolive by 4.5% during the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company's stock valued at $228,000 after acquiring an additional 101 shares in the last quarter. BLB&B Advisors LLC boosted its position in Colgate-Palmolive by 2.5% in the second quarter. BLB&B Advisors LLC now owns 4,337 shares of the company's stock valued at $421,000 after buying an additional 104 shares in the last quarter. D Orazio & Associates Inc. boosted its position in Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock valued at $297,000 after buying an additional 108 shares in the last quarter. Finally, ZWJ Investment Counsel Inc. boosted its position in Colgate-Palmolive by 3.1% in the second quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company's stock valued at $349,000 after buying an additional 109 shares in the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock traded up $0.30 during trading hours on Wednesday, reaching $93.91. 4,302,427 shares of the stock were exchanged, compared to its average volume of 4,390,289. The company has a market cap of $76.73 billion, a P/E ratio of 26.90, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a twelve month low of $75.39 and a twelve month high of $109.30. The stock has a 50 day moving average of $98.80 and a two-hundred day moving average of $98.56.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.13%. Colgate-Palmolive's payout ratio is 57.31%.

Insiders Place Their Bets

In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 16.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price target on the stock. StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Thursday, November 14th. TD Cowen dropped their target price on shares of Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Monday, October 28th. Morgan Stanley boosted their target price on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an "overweight" rating in a research note on Monday, July 29th. Finally, UBS Group boosted their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a "buy" rating in a research note on Wednesday, September 4th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.